{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:51:11Z","timestamp":1793263871373,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vhri.2025.101562","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:52:44Z","timestamp":1766487164000},"page":"101562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Drug Market in Brazil: An Analysis of Drug Discontinuation From 2018 to 2022"],"prefix":"10.1016","volume":"54","author":[{"given":"Naiane Lima","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mariano","family":"Ruas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vhri.2025.101562_bib1","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311x00254720","article-title":"Vulnerabilidades das ind\u00fastrias nacionais de medicamentos e produtos biotecnol\u00f3gicos no contexto da pandemia de COVID-19","volume":"37","author":"Fernandes","year":"2021","journal-title":"Cad Saude Publ"},{"issue":"4","key":"10.1016\/j.vhri.2025.101562_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0048-7333(00)00093-7","article-title":"The dynamics of technological innovation: the case of the pharmaceutical industry","volume":"30","author":"Achilladelis","year":"2001","journal-title":"Res Policy"},{"issue":"1","key":"10.1016\/j.vhri.2025.101562_bib3","doi-asserted-by":"crossref","DOI":"10.1590\/s0103-73312018280104","article-title":"A evolu\u00e7\u00e3o recente da ind\u00fastria farmac\u00eautica brasileira nos limites da subordina\u00e7\u00e3o econ\u00f4mica","volume":"28","author":"Rodrigues","year":"2018","journal-title":"Physis: Rev Sa\u00fade Colet"},{"key":"10.1016\/j.vhri.2025.101562_bib4","author":"Magalh\u00e3es"},{"key":"10.1016\/j.vhri.2025.101562_bib6","first-page":"43","article-title":"H\u00e1 Espa\u00e7os Competitivos Para A Ind\u00fastria Farmoqu\u00edmica Brasileira? Reflex\u00f5es e Propostas Para Pol\u00edticas P\u00fablicas","author":"Mitidieri","year":"2013","journal-title":"Complexo Industrial da Sa\u00fade"},{"issue":"2","key":"10.1016\/j.vhri.2025.101562_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5585\/rgss.v5i2.194","article-title":"A depend\u00eancia de insumos farmac\u00eauticos importados no Brasil: um estudo de caso do Medicamento antirretroviral nevirapina no laborat\u00f3rio farmac\u00eautico oficial Farmanguinhos","volume":"5","author":"Dias","year":"2016","journal-title":"Rev Gest\u00e3o Sistem Sa\u00fade"},{"issue":"8","key":"10.1016\/j.vhri.2025.101562_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003509","article-title":"COVID-19: transformative actions for more equitable, resilient, sustainable societies and health systems in the Americas","volume":"5","author":"Etienne","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101562_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.6004\/jnccn.2020.7560","article-title":"Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal","volume":"18","author":"Ueda","year":"2020","journal-title":"J Natl Compr Cancer Netw, Abril de"},{"issue":"2","key":"10.1016\/j.vhri.2025.101562_bib18","doi-asserted-by":"crossref","first-page":"828","DOI":"10.30968\/rbfhss.2022.132.0828","article-title":"Enfrentamento da escassez de tecnologias em sa\u00fade gerada pela crise sanit\u00e1ria global: a\u00e7\u00f5es conjuntas de entidades cient\u00edficas brasileiras","volume":"13","author":"Bezerra","year":"2022","journal-title":"Rev Bras Farm Hospitalar Serv Sa\u00fade"},{"key":"10.1016\/j.vhri.2025.101562_bib19","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20240079","article-title":"Estat\u00edstica Cardiovascular \u2013 Brasil 2023","volume":"121","author":"Oliveira","year":"2024","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"10.1016\/j.vhri.2025.101562_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jval.2018.04.1826","article-title":"Predictors of drug shortages and association with generic drug prices: a retrospective cohort study","volume":"21","author":"Dave","year":"2018","journal-title":"Value Health"},{"issue":"26","key":"10.1016\/j.vhri.2025.101562_bib22","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1056\/NEJMc1711899","article-title":"Prices of generic drugs associated with numbers of manufacturers","volume":"377","author":"Dave","year":"2017","journal-title":"N Engl J Med"},{"issue":"121","key":"10.1016\/j.vhri.2025.101562_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1590\/0103-1104201912120","article-title":"Santos Mab dos, pinto CDBS. Regula\u00e7\u00e3o contempor\u00e2nea de pre\u00e7os de medicamentos no Brasil - uma an\u00e1lise cr\u00edtica","volume":"43","author":"Dias","year":"2019","journal-title":"Sa\u00fade Debate, Abril de"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925004881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925004881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:37:26Z","timestamp":1783438646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925004881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":13,"alternative-id":["S2212109925004881"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101562","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Market in Brazil: An Analysis of Drug Discontinuation From 2018 to 2022","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101562"}}